Mandate

Vinge advises BRITAX

May 14, 2013

Vinge has advised BRITAX in connection with the acquisition of Brio’s business operations within the areas of push chairs, child car seats and furniture. BRITAX is one of the world’s leading manufacturers and suppliers of child car seats and push chairs. BRITAX’s head office is located in Great Britain. In addition, the company has facilities in Great Britain, Germany, Australia and the US. BRITAX is owned by Nordic Capital Fund VII.

Vinge’s team consisted of partner Magnus Pauli together with associates Gabriel Westin, Josefin Erikson, Yohanna Öhrenegård and Jonas Lindblad.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026